The Effect of Intranasal Oxytocin on Headache Intensity and Headache-associated Symptoms in Patients Suffering From Chronic Daily Headache.
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2016
At a glance
- Drugs Oxytocin (Primary)
- Indications Migraine; Tension type headache
- Focus Therapeutic Use
- 30 Mar 2016 According to a Trigemina media release, data of this trial will be presented at the BIO-Europe Spring 2016 Conference.
- 08 Sep 2011 Actual end date 1 Aug 2010 added as reported by ClinicalTrials.gov.
- 08 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.